日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO)

Talimogene laherparepvec 和 atezolizumab 在新辅助化疗后 HER2 阴性乳腺癌中的应用：一项机会窗口 II 期试验 (SOLTI-1503 PROMETEO)

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-69222-5
Pascual, Tomás; Vidal, Maria; Cejalvo, Juan M; Vega, Estela; Sanfeliu, Esther; Villacampa, Guillermo; Ganau, Sergi; Parreño, Ana María Julve; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begoña; Seguí, Elia; Brasó-Maristanty, Fara; de la Cruz-Merino, Luis; Juan, Manel; Galván, Patricia; Gonzàlez-Farré, Xavier; Chillara, Samyukta; Villagrasa, Patricia; Pfefferle, Adam D; O'Connell, Constandina E; Ferrero-Cafiero, Juan M; Oliveira, Mafalda; Perou, Charles M; Prat, Aleix
肿瘤
HER2
肿瘤免疫
乳腺癌
MET
发表日期：2026
文献求助 收藏

Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer

HER2DX基因组检测与HER2阳性乳腺癌生物学和病理特征的关联

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-3123
Sanfeliu, Esther; Martínez-Romero, Anabel; Marín-Aguilera, Mercedes; Cobo, Sandra; González-Farré, Blanca; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butillé, Joan Antón; Muñoz, Montserrat; Gómez-Bravo, Raquel; Tapia, Marta; Tebar, Cristina; Saura, Cristina; Escrivà-de-Romaní, Santiago; Soberino, Jesús; Cortés, Javier; Morales, Serafin; Amillano, Kepa; Paré, Laia; Villagrasa, Patricia; Buckingham, Wesley; Pardo, Francisco; Parker, Joel S; Brasó-Maristany, Fara; Ciruelos, Eva; Sánchez-Bayona, Rodrigo; Martinez-Sáez, Olga; Cejalvo, Juan Miguel; Prat, Aleix
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Pembrolizumab and Paclitaxel in Patients with HR+/HER2- Breast Cancer with HER2-Enriched or Basal-like Subtypes

帕博利珠单抗联合紫杉醇治疗 HR+/HER2- 乳腺癌患者，包括 HER2 富集型或基底样亚型

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-2570
Conte, Benedetta; Brasó-Maristany, Fara; Pascual, Tomás; Hernando, Cristina; Vázquez, Silvia; Blanch, Salvador; Oliveira, Mafalda; Virizuela, Juan Antonio; Muñoz, Montserrat; Seguí, Elia; Rodriguez-Hernandez, Adela; Vidal Losada, Maria Jesus; Galván, Patricia; Castillo, Oleguer; Blasco, Paula; Alva, Manuel; Chic, Nuria; Sanfeliu, Esther; Cano-Crespo, Sara; Salvador, Fernando; Villacampa, Guillermo; Villanueva, Lorea; Ferrero-Cafiero, Juan Manuel; Vivancos, Ana; Prat, Aleix; Ciruelos, Eva
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane

验证 HER2DX 基因组检测在接受曲妥珠单抗、帕妥珠单抗和紫杉烷一线治疗的 HER2 阳性晚期乳腺癌患者中的应用价值

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-026-00909-0
Kubeczko, Marcin; Cobo, Sandra; Sanchez-Bayona, Rodrigo; Pyciński, Bartłomiej; Soberino, Jesús; Chmielik, Ewa; Sanfeliu, Esther; Rey, Maria; Pardo, Francisco; Aguirre, Angela; Castillo, Oleguer; Lesniak, Aleksandra; Oczko-Wojciechowska, Malgorzata; Carcelero, Esther; Adamo, Barbara; Vidal, Maria; Bergamino, Milana; Maues, Julia; Villacampa, Guillermo; Paré, Laia; Villagrasa, Patricia; Ciruelos, Eva; Prat, Aleix; Jarzab, Michal; Brasó-Maristany, Fara
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy

HER2DX 在老年 HER2 阳性早期乳腺癌患者中的应用：曲妥珠单抗±化疗 RESPECT 试验的长期随访结果

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-65599-x
Nozawa, Kazuki; Sawaki, Masataka; Uemura, Yukari; Tsuneizumi, Michiko; Takano, Toshimi; Gondo, Naomi; Hara, Fumikata; Harao, Michiko; Toyama, Tatsuya; Taira, Naruto; Vivancos, Ana; Perou, Charles M; Sanfeliu, Esther; Brasó-Maristany, Fara; Parker, Joel S; Buckingham, Wesley; Paré, Laia; Villacampa, Guillermo; Marín-Aguilera, Mercedes; Villagrasa, Patricia; Prat, Aleix; Iwata, Hiroji
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial

雌激素受体阳性、HER2阴性早期乳腺癌女性患者接受Elacestrant治疗：术前治疗窗口期ELIPSE试验结果

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2460
Vidal, Maria; Falato, Claudette; Pascual, Tomás; Sanchez-Bayona, Rodrigo; Muñoz-Mateu, Montserrat; Cebrecos, Isaac; Gonzalez-Farré, Xavier; Cortadellas, Tomás; Margelí Vila, Mireia; Luna, Miguel A; Siso, Christian; Amillano, Kepa; Galván, Patricia; Bergamino, Milana A; Ferrero-Cafiero, Juan M; Salvador, Fernando; Espinosa Guerrero, Alejandra; Pare, Laia; Sanfeliu, Esther; Prat, Aleix; Bellet, Meritxell
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative review

一例极年轻HER2阳性乳腺癌患者发生紫杉醇相关I型Kounis综合征的病例报告及叙述性综述，探讨基因组学在解析复杂治疗方案中的作用：病例报告及叙述性综述

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104465
Muñoz, Javier; Nucera, Sabrina; Rubira Garcia, Nuria; Cebrecos, Isaac; Oses, Gabriela; Ganau, Sergi; Sanfeliu, Esther; Jares, Pedro; Marín-Aguilera, Mercedes; Galván, Patricia; Brasó-Maristany, Fara; Martínez-Sáez, Olga; Cascos, Enric; Font, Carme; Schettini, Francesco
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab

HER2DX ERBB2 mRNA评分在接受化疗、曲妥珠单抗和帕妥珠单抗一线治疗的HER2阳性晚期乳腺癌患者中的应用

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-025-00753-8
Sánchez-Bayona, Rodrigo; Martínez-Sáez, Olga; Romero-Romero, Denys; Seguí, Elia; Carcelero, Esther; Tolosa, Pablo; Soberino, Jesús; Alva, Manuel; Pascual, Tomás; Lema, Laura; Garcia-Fructuoso, Isabel; Cobos-Fernandez, Maria Angeles; Rey, Maria; Manso, Luis; Aguirre, Angela; Madariaga, Ainhoa; Sirenko, Valeria; González-Deza, Cristina; Blasco, Paula; Mayhua, Astrid; Castillo, Oleguer; Galván, Patricia; Sanfeliu, Esther; Villacampa, Guillermo; Buckingham, Wesley; Marín-Aguilera, Mercedes; Paré, Laia; Villagrasa, Patricia; Perou, Charles M; Maues, Julia; Brasó-Maristany, Fara; Ciruelos, Eva; Prat, Aleix
肿瘤
HER2
肿瘤免疫
ERBB2
乳腺癌
发表日期：2025
文献求助 收藏

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study

基于血液预后评分和免疫治疗早期动态变化的转移性实体瘤患者预后选择：一项前瞻性纵向研究

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03933-w
García-Corbacho, Javier; Indacochea, Alberto; Victoria, Iván; Moreno, Débora; Angelats, Laura; González Navarro, Azucena E; Mezquita, Laura; Brasó-Maristany, Fara; Galván, Patricia; Mellado, Begoña; Viñolas, Nuria; Sauri, Tamara; Nogué, Miquel; Adamo, Barbara; Maurel, Joan; Pineda, Estela; Gaba, Lydia; Reig, Oscar; Basté, Neus; Sanfeliu, Esther; Juan, Manel; Prat, Aleix; Schettini, Francesco
免疫/内分泌
发表日期：2025
文献求助 收藏

Case Report: Personalized management of HER2-positive breast cancer with advanced nodal disease during pregnancy: a clinical case and review

病例报告：妊娠期HER2阳性乳腺癌伴晚期淋巴结转移的个体化管理：一例临床病例及综述

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1672751
Gullotta, Carla; Walbaum, Benjamin; Seguí, Elia; López, Marta; Mension, Eduard; Cebrecos, Isaac; Molla, Meritxell; Oses, Gabriela; Bargalló, Xavier; Ganau-Macias, Sergi; Sanfeliu, Esther; Braso-Maristany, Fara; Muñoz, Montserrat; Prat, Aleix; Vidal, María; Adamo, Barbara
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏